R, T., BO, D., EY, M., & JH, K. (2024). Nanotherapeutic strategy against glioblastoma using enzyme inhibitors. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 181, 117713. https://doi.org/10.1016/j.biopha.2024.117713
Chicago Style (17th ed.) CitationR, Thiruvengadam, Dareowolabi BO, Moon EY, and Kim JH. "Nanotherapeutic Strategy Against Glioblastoma Using Enzyme Inhibitors." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 181 (2024): 117713. https://doi.org/10.1016/j.biopha.2024.117713.
MLA (9th ed.) CitationR, Thiruvengadam, et al. "Nanotherapeutic Strategy Against Glioblastoma Using Enzyme Inhibitors." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 181, 2024, p. 117713, https://doi.org/10.1016/j.biopha.2024.117713.